Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Oct 21
 -0.93 / -2.46%
Today’s Change
Today|||52-Week Range
The Medicines Co. Reports Positive Phase II Data on PCSK9si
Oct 19 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO
Oct 12 / Zacks.com - Paid Partner Content
Weekly Top Insider Buys Highlight for Week of Oct. 14
Oct 16 / GuruFocus News - Paid Partner Content
Kamada (KMDA) Extends Partnership with Shire for Glassia
Oct 10 / Zacks.com - Paid Partner Content
Alnylam (ALNY) to Continue Phase III Study on Patisiran
Oct 12 / Zacks.com - Paid Partner Content
Better Buy: Alnylam Pharmaceuticals, Inc. vs. Sarepta Therapeutics, Inc.
Oct 10 / MotleyFool.com - Paid Partner Content